{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:17:41Z","timestamp":1787883461401,"version":"build-2784847793"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-026-06164-5","type":"journal-article","created":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:55:56Z","timestamp":1787882156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quercetin as a Hypothesized Involvement of VMAT2 in Neurodegenerative Diseases\u2014Mechanistic Insight and Therapeutic Applications"],"prefix":"10.1007","volume":"63","author":[{"given":"Kanishka","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vir","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Jamwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumyadeep","family":"Bhaumik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7939-8706","authenticated-orcid":false,"family":"Rohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9931-1113","authenticated-orcid":false,"given":"Rinka","family":"Juneja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,28]]},"reference":[{"issue":"3","key":"6164_CR1","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J (2022) A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci 23(3):1851. https:\/\/doi.org\/10.3390\/ijms23031851","journal-title":"Int J Mol Sci"},{"issue":"6","key":"6164_CR2","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3390\/pharmaceutics16060708","volume":"16","author":"L Sequeira","year":"2024","unstructured":"Sequeira L, Benfeito S, Fernandes C, Lima I, Peixoto J, Alves C et al (2024) Drug development for Alzheimer\u2019s and Parkinson\u2019s disease: where do we go now? Pharmaceutics 16(6):708. https:\/\/doi.org\/10.3390\/pharmaceutics16060708","journal-title":"Pharmaceutics"},{"issue":"11","key":"6164_CR3","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/antiox11112167","volume":"11","author":"MC Jurc\u0103u","year":"2022","unstructured":"Jurc\u0103u MC, Andronie-Cioara FL, Jurc\u0103u A, Marcu F, \u0162i\u021b DM, Pa\u0219cal\u0103u N et al (2022) The link between oxidative stress, mitochondrial dysfunction and neuroinflammation in the pathophysiology of Alzheimer\u2019s disease: therapeutic implications and future perspectives. Antioxidants 11(11):2167. https:\/\/doi.org\/10.3390\/antiox11112167","journal-title":"Antioxidants"},{"key":"6164_CR4","doi-asserted-by":"publisher","unstructured":"Vollmannov\u00e1 A, Boj\u0148ansk\u00e1 T, Musilov\u00e1 J, Lidikov\u00e1 J, Cifrov\u00e1 M (2024) Quercetin as one of the most abundant represented biological valuable plant components with remarkable chemoprotective effects-a review. Heliyon 10(12). https:\/\/doi.org\/10.1016\/j.heliyon.2024.e33342","DOI":"10.1016\/j.heliyon.2024.e33342"},{"issue":"1","key":"6164_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"H Khan","year":"2019","unstructured":"Khan H, Ullah H, Aschner M, Cheang WS, Akkol EK (2019) Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules 10(1):59. https:\/\/doi.org\/10.3390\/biom10010059","journal-title":"Biomolecules"},{"issue":"2","key":"6164_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12035-009-8059-y","volume":"39","author":"TS Guillot","year":"2009","unstructured":"Guillot TS, Miller GW (2009) Protective actions of the vesicular monoamine transporter 2 (VMAT2) in monoaminergic neurons. Mol Neurobiol 39(2):149\u201370. https:\/\/doi.org\/10.1007\/s12035-009-8059-y","journal-title":"Mol Neurobiol"},{"key":"6164_CR7","doi-asserted-by":"publisher","unstructured":"Alwindi M, Bizanti A (2023) Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions. Heliyon 9(11). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22413","DOI":"10.1016\/j.heliyon.2023.e22413"},{"issue":"7\u20138","key":"6164_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.nut.2010.09.002","volume":"27","author":"S Yoshino","year":"2011","unstructured":"Yoshino S, Hara A, Sakakibara H, Kawabata K, Tokumura A, Ishisaka A et al (2011) Effect of quercetin and glucuronide metabolites on the monoamine oxidase-a reaction in mouse brain mitochondria. Nutrition 27(7\u20138):847\u201352. https:\/\/doi.org\/10.1016\/j.nut.2010.09.002","journal-title":"Nutrition"},{"issue":"4","key":"6164_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11064-025-04447-2","volume":"50","author":"HS Mohammed","year":"2025","unstructured":"Mohammed HS, Hosny EN, Sawie HG, Khadrawy YA (2025) Assessment of the therapeutic potential of hesperidin and quercetin nanoparticles on oxidative stress, enzyme activities, trophic factors, and monoamines in an animal model of depression. Neurochem Res 50(4):203. https:\/\/doi.org\/10.1007\/s11064-025-04447-2","journal-title":"Neurochem Res"},{"issue":"7","key":"6164_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s11910-013-0362-3","volume":"13","author":"SP Alter","year":"2013","unstructured":"Alter SP, Lenzi GM, Bernstein AI, Miller GW (2013) Vesicular integrity in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 13(7):362. https:\/\/doi.org\/10.1007\/s11910-013-0362-3","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"9","key":"6164_CR11","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s11055-017-0508-x","volume":"47","author":"IV Ekimova","year":"2017","unstructured":"Ekimova IV, Plaksina DV (2017) Effects of quercetin on neurodegenerative and compensatory processes in the nigrostriatal system in a model of the preclinical stage of Parkinson\u2019s disease in rats. Neurosci Behav Physiol 47(9):1029\u201336. https:\/\/doi.org\/10.1007\/s11055-017-0508-x","journal-title":"Neurosci Behav Physiol"},{"key":"6164_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102357","volume":"99","author":"DG Gadhave","year":"2024","unstructured":"Gadhave DG, Sugandhi VV, Jha SK, Nangare SN, Gupta G, Singh SK et al (2024) Neurodegenerative disorders: mechanisms of degeneration and therapeutic approaches with their clinical relevance. Ageing Res Rev 99:102357. https:\/\/doi.org\/10.1016\/j.arr.2024.102357","journal-title":"Ageing Res Rev"},{"issue":"3","key":"6164_CR13","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1162\/netn_a_00458","volume":"9","author":"S Jin","year":"2025","unstructured":"Jin S, Li J, Wang J (2025) Brain connectome from neuronal morphology. Netw Neurosci 9(3):913\u201337. https:\/\/doi.org\/10.1162\/netn_a_00458","journal-title":"Netw Neurosci"},{"issue":"1","key":"6164_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41580-022-00510-w","volume":"24","author":"A Brunet","year":"2023","unstructured":"Brunet A, Goodell MA, Rando TA (2023) Ageing and rejuvenation of tissue stem cells and their niches. Nat Rev Mol cell Biol 24(1):45\u201362. https:\/\/doi.org\/10.1038\/s41580-022-00510-w","journal-title":"Nat Rev Mol cell Biol"},{"issue":"3","key":"6164_CR15","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1136\/pn-2023-003988","volume":"24","author":"PW Cullinane","year":"2024","unstructured":"Cullinane PW, Wrigley S, Bezerra Parmera J, Valerio F, Millner TO, Shaw K et al (2024) Pathology of neurodegenerative disease for the general neurologist. Pract Neurol 24(3):188\u201399. https:\/\/doi.org\/10.1136\/pn-2023-003988","journal-title":"Pract Neurol"},{"issue":"12","key":"6164_CR16","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.3390\/ijms26125743","volume":"26","author":"M Kukolj","year":"2025","unstructured":"Kukolj M, Or\u0161oli\u0107 N, Langer Horvat L, Nikoli\u0107 B, Ocrt T, Branovi\u0107 \u010cakani\u0107 K et al (2025) Quercetin as a therapeutic option in a rat model of aluminum chloride-and D-galactose-induced neurodegeneration. Int J Mol Sci 26(12):5743. https:\/\/doi.org\/10.3390\/ijms26125743","journal-title":"Int J Mol Sci"},{"issue":"5","key":"6164_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/brainsci15050485","volume":"15","author":"J Kruszka","year":"2025","unstructured":"Kruszka J, Marty\u0144ski J, Szewczyk-Golec K, Wo\u017aniak A, Nuszkiewicz J (2025) The role of selected flavonoids in modulating neuroinflammation in Alzheimer\u2019s disease: mechanisms and therapeutic potential. Brain Sci 15(5):485. https:\/\/doi.org\/10.3390\/brainsci15050485","journal-title":"Brain Sci"},{"issue":"15","key":"6164_CR18","doi-asserted-by":"publisher","first-page":"e70108","DOI":"10.1002\/mnfr.70108","volume":"69","author":"L Garz\u00f3n\u2010Garc\u00eda","year":"2025","unstructured":"Garz\u00f3n\u2010Garc\u00eda L, Ayuda\u2010Dur\u00e1n B, Gonz\u00e1lez\u2010Manzano S, Santos\u2010Buelga C, Gonz\u00e1lez\u2010Param\u00e1s AM (2025) Neuroprotective potential of the flavonoids quercetin and epicatechin in a C. elegans tauopathy model. Mol Nutr Food Res 69(15):e70108. https:\/\/doi.org\/10.1002\/mnfr.70108","journal-title":"Mol Nutr Food Res"},{"key":"6164_CR19","doi-asserted-by":"publisher","first-page":"1593264","DOI":"10.3389\/fphar.2025.1593264","volume":"16","author":"M Adnan","year":"2025","unstructured":"Adnan M, Siddiqui AJ, Bardakci F, Surti M, Badraoui R, Patel M (2025) Neuroprotective potential of quercetin in Alzheimer\u2019s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-\u03b2 aggregation. Front Pharmacol 16:1593264. https:\/\/doi.org\/10.3389\/fphar.2025.1593264","journal-title":"Front Pharmacol"},{"key":"6164_CR20","doi-asserted-by":"publisher","unstructured":"Alam A, Tamkeen N, Imam N, Farooqui A, Ahmed MM, Tazyeen S et al (2018) Pharmacokinetic and molecular docking studies of plant-derived natural compounds to exploring potential anti-Alzheimer activity. In: In Silico Approach for Sustainable Agriculture. Springer p. 217\u201338. https:\/\/doi.org\/10.1007\/978-981-13-0347-0_13","DOI":"10.1007\/978-981-13-0347-0_13"},{"key":"6164_CR21","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2024.73","volume":"5","author":"AN Panche","year":"2016","unstructured":"Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https:\/\/doi.org\/10.1017\/jns.2024.73","journal-title":"J Nutr Sci"},{"key":"6164_CR22","doi-asserted-by":"publisher","first-page":"6038996","DOI":"10.1155\/2022\/6038996","volume":"1","author":"T Minocha","year":"2022","unstructured":"Minocha T, Birla H, Obaid AA, Rai V, Sushma P, Shivamallu C et al (2022) (2022) Flavonoids as promising neuroprotectants and their therapeutic potential against Alzheimer\u2019s disease. Oxid Med Cell Longev 1:6038996. https:\/\/doi.org\/10.1155\/2022\/6038996","journal-title":"Oxid Med Cell Longev"},{"issue":"17","key":"6164_CR23","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.3390\/ijms231710020","volume":"23","author":"J Li","year":"2022","unstructured":"Li J, Sun M, Cui X, Li C (2022) Protective effects of flavonoids against Alzheimer\u2019s disease: pathological hypothesis, potential targets, and structure\u2013activity relationship. Int J Mol Sci 23(17):10020. https:\/\/doi.org\/10.3390\/ijms231710020","journal-title":"Int J Mol Sci"},{"key":"6164_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpbup.2025.100177","volume":"7","author":"MN Kadhim","year":"2025","unstructured":"Kadhim MN, Al-Shammary D, Mahdi AM, Ibaida A (2025) Feature selection based on Mahalanobis distance for early Parkinson disease classification. Comput Methods Programs Biomed Updat 7:100177. https:\/\/doi.org\/10.1016\/j.cmpbup.2025.100177","journal-title":"Comput Methods Programs Biomed Updat"},{"issue":"16","key":"6164_CR25","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1001\/jama.2014.3654","volume":"311","author":"BS Connolly","year":"2014","unstructured":"Connolly BS, Lang AE (2014) Pharmacological treatment of Parkinson disease: a review. Jama 311(16):1670\u201383. https:\/\/doi.org\/10.1001\/jama.2014.3654","journal-title":"Jama"},{"key":"6164_CR26","doi-asserted-by":"publisher","unstructured":"Kumar L, Malhotra M, Singh AP, Singh AP (2024) Comprehensive review on Parkinson\u2019s disease: insights into prevalence, pathophysiology, diagnosis, and multifaceted treatment approaches. J Drug Deliv Ther 14(6). https:\/\/doi.org\/10.22270\/jddt.v14i6.6637","DOI":"10.22270\/jddt.v14i6.6637"},{"issue":"2","key":"6164_CR27","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3233\/JHD-231523","volume":"13","author":"M Oosterloo","year":"2024","unstructured":"Oosterloo M, Touze A, Byrne LM, Achenbach J, Aksoy H, Coleman A et al (2024) Clinical review of juvenile Huntington\u2019s disease. J Huntingtons Dis 13(2):149\u201361. https:\/\/doi.org\/10.3233\/JHD-231523","journal-title":"J Huntingtons Dis"},{"issue":"3","key":"6164_CR28","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/18796397251338207","volume":"14","author":"A Blusch","year":"2025","unstructured":"Blusch A, Bj\u00f6rkqvist M (2025) Neuroinflammation in Huntington\u2019s disease: causes, consequences, and treatment strategies. J Huntingtons Dis 14(3):258\u201369. https:\/\/doi.org\/10.1177\/18796397251338207","journal-title":"J Huntingtons Dis"},{"key":"6164_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.665031","volume":"12","author":"MS Islam","year":"2021","unstructured":"Islam MS, Quispe C, Hossain R, Islam MT, Al-Harrasi A, Al-Rawahi A et al (2021) Neuropharmacological effects of quercetin: a literature-based review. Front Pharmacol 12:665031. https:\/\/doi.org\/10.3389\/fphar.2021.665031","journal-title":"Front Pharmacol"},{"issue":"1","key":"6164_CR30","doi-asserted-by":"publisher","first-page":"978","DOI":"10.15212\/bioi-2025-0073","volume":"6","author":"I Debnath","year":"2025","unstructured":"Debnath I, Ghosh S, Bhunia S, Nayak A, Basak S, Nandi S et al (2025) Mechanistic insights and therapeutic potential of quercetin in neuroprotection: a comprehensive review of pathways and clinical perspectives. BIO Integr 6(1):978. https:\/\/doi.org\/10.15212\/bioi-2025-0073","journal-title":"BIO Integr"},{"key":"6164_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.lfs.2019.116616","volume":"224","author":"E Zaplatic","year":"2019","unstructured":"Zaplatic E, Bule M, Shah SZA, Uddin MS, Niaz K (2019) Molecular mechanisms underlying protective role of quercetin in attenuating Alzheimer\u2019s disease. Life Sci 224:109\u201319. https:\/\/doi.org\/10.1016\/j.lfs.2019.116616","journal-title":"Life Sci"},{"issue":"2","key":"6164_CR32","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/ijms21020493","volume":"21","author":"XW Zhang","year":"2020","unstructured":"Zhang XW, Chen JY, Ouyang D, Lu JH (2020) Quercetin in animal models of Alzheimer\u2019s disease: a systematic review of preclinical studies. Int J Mol Sci 21(2):493. https:\/\/doi.org\/10.3390\/ijms21020493","journal-title":"Int J Mol Sci"},{"issue":"1\u20132","key":"6164_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.ijpharm.2016.11.061","volume":"517","author":"E Puerta","year":"2017","unstructured":"Puerta E, Su\u00e1rez-Santiago JE, Santos-Magalh\u00e3es NS, Ramirez MJ, Irache JM (2017) Effect of the oral administration of nanoencapsulated quercetin on a mouse model of Alzheimer\u2019s disease. Int J Pharm 517(1\u20132):50\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.11.061","journal-title":"Int J Pharm"},{"issue":"4","key":"6164_CR34","doi-asserted-by":"publisher","first-page":"633","DOI":"10.21608\/ejchem.2021.99971.4647","volume":"65","author":"HA Elreedy","year":"2022","unstructured":"Elreedy HA, Elfiky AM, Mahmoud AA, Ibrahim KS, Ghazy MA (2022) Effect of quercetin as therapeutic and protective agent in aluminum chloride-induced Alzheimer\u2019s disease rats. Egypt J Chem 65(4):633\u201341. https:\/\/doi.org\/10.21608\/ejchem.2021.99971.4647","journal-title":"Egypt J Chem"},{"key":"6164_CR35","unstructured":"A Review of quercetin: chemistry, antioxident properties, and bioavailability (2017) Journal of young investigators. [cited 12-Jan-2026]. Available from:\u00a0https:\/\/www.jyi.org\/2009-april\/2017\/10\/15\/a-review-of-quercetin-chemistry-antioxidant-properties-and-bioavailability"},{"issue":"3","key":"6164_CR36","doi-asserted-by":"publisher","first-page":"374","DOI":"10.3390\/foods9030374","volume":"9","author":"GES Batiha","year":"2020","unstructured":"Batiha GES, Beshbishy AM, Ikram M, Mulla ZS, El-Hack MEA, Taha AE et al (2020) The pharmacological activity, biochemical properties, and pharmacokinetics of the major natural polyphenolic flavonoid: quercetin. Foods 9(3):374. https:\/\/doi.org\/10.3390\/foods9030374","journal-title":"Foods"},{"issue":"1","key":"6164_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3390\/biom15010151","volume":"15","author":"HOA Alharbi","year":"2025","unstructured":"Alharbi HOA, Alshebremi M, Babiker AY, Rahmani AH (2025) The role of quercetin, a flavonoid in the management of pathogenesis through regulation of oxidative stress, inflammation, and biological activities. Biomolecules 15(1):151. https:\/\/doi.org\/10.3390\/biom15010151","journal-title":"Biomolecules"},{"issue":"4","key":"6164_CR38","doi-asserted-by":"publisher","first-page":"653","DOI":"10.3390\/nu17040653","volume":"17","author":"E Baranowska-W\u00f3jcik","year":"2025","unstructured":"Baranowska-W\u00f3jcik E, Gajowniczek-A\u0142asa D, Pawlikowska-Pawl\u0119ga B, Szwajgier D (2025) The potential role of phytochemicals in Alzheimer\u2019s disease. Nutrients 17(4):653. https:\/\/doi.org\/10.3390\/nu17040653","journal-title":"Nutrients"},{"key":"6164_CR39","first-page":"1","volume":"13","author":"SM Pasumarthy","year":"2025","unstructured":"Pasumarthy SM (2025) A review on herbs used in the treatment of Alzheimer\u2019s disease. EC Pharmacol Toxicol 13:1\u201321","journal-title":"EC Pharmacol Toxicol"},{"key":"6164_CR40","doi-asserted-by":"publisher","unstructured":"Engelhardt E, Resende E de PF, Gomes KB (2024) Physiopathological mechanisms underlying Alzheimer\u2019s disease: a narrative review. Dement Neuropsychol 18:e2024VR01. https:\/\/doi.org\/10.1590\/1980-5764-DN-2024-VR01","DOI":"10.1590\/1980-5764-DN-2024-VR01"},{"issue":"1","key":"6164_CR41","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1471-2377-11-75","volume":"11","author":"AM Enciu","year":"2011","unstructured":"Enciu AM, Nicolescu MI, Manole CG, Mure\u015fanu DF, Popescu LM, Popescu BO (2011) Neuroregeneration in neurodegenerative disorders. BMC Neurol 11(1):75. https:\/\/doi.org\/10.1186\/1471-2377-11-75","journal-title":"BMC Neurol"},{"issue":"1","key":"6164_CR42","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13024-019-0320-x","volume":"14","author":"D Twohig","year":"2019","unstructured":"Twohig D, Nielsen HM (2019) \u03b1-synuclein in the pathophysiology of Alzheimer\u2019s disease. Mol Neurodegener 14(1):23. https:\/\/doi.org\/10.1186\/s13024-019-0320-x","journal-title":"Mol Neurodegener"},{"key":"6164_CR43","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.742408","volume":"14","author":"MB Abubakar","year":"2022","unstructured":"Abubakar MB, Sanusi KO, Ugusman A, Mohamed W, Kamal H, Ibrahim NH et al (2022) Alzheimer\u2019s disease: an update and insights into pathophysiology. Front Aging Neurosci 14:742408. https:\/\/doi.org\/10.3389\/fnagi.2022.742408","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"6164_CR44","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3892\/br.2016.630","volume":"4","author":"WJ Huang","year":"2016","unstructured":"Huang WJ, Zhang XIA, Chen WW (2016) Role of oxidative stress in Alzheimer\u2019s disease. Biomed reports 4(5):519\u201322. https:\/\/doi.org\/10.3892\/br.2016.630","journal-title":"Biomed reports"},{"issue":"3","key":"6164_CR45","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1159\/000007969","volume":"40","author":"JP Brion","year":"1998","unstructured":"Brion JP (1998) Neurofibrillary tangles and Alzheimer\u2019s disease. Eur Neurol 40(3):130\u201340. https:\/\/doi.org\/10.1159\/000007969","journal-title":"Eur Neurol"},{"issue":"11","key":"6164_CR46","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1586\/14737175.8.11.1703","volume":"8","author":"EJ Mufson","year":"2008","unstructured":"Mufson EJ, Counts SE, Perez SE, Ginsberg SD (2008) Cholinergic system during the progression of Alzheimer\u2019s disease: therapeutic implications. Expert Rev Neurother 8(11):1703\u201318. https:\/\/doi.org\/10.1586\/14737175.8.11.1703","journal-title":"Expert Rev Neurother"},{"issue":"6","key":"6164_CR47","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.3390\/molecules27061816","volume":"27","author":"ZR Chen","year":"2022","unstructured":"Chen ZR, Huang JB, Yang SL, Hong FF (2022) Role of cholinergic signaling in Alzheimer\u2019s disease. Molecules 27(6):1816. https:\/\/doi.org\/10.3390\/molecules27061816","journal-title":"Molecules"},{"issue":"9","key":"6164_CR48","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.3390\/biomedicines13092283","volume":"13","author":"S Yeo","year":"2025","unstructured":"Yeo S (2025) Recent advances in Parkinson\u2019s disease research: from pathophysiology to novel therapeutic approaches. Biomedicines 13(9):2283. https:\/\/doi.org\/10.3390\/biomedicines13092283","journal-title":"Biomedicines"},{"issue":"16","key":"6164_CR49","doi-asserted-by":"publisher","first-page":"13021","DOI":"10.3390\/ijms241613021","volume":"24","author":"A Jiang","year":"2023","unstructured":"Jiang A, Handley RR, Lehnert K, Snell RG (2023) From pathogenesis to therapeutics: a review of 150 years of Huntington\u2019s disease research. Int J Mol Sci 24(16):13021. https:\/\/doi.org\/10.3390\/ijms241613021","journal-title":"Int J Mol Sci"},{"key":"6164_CR50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuint.2013.12.003","volume":"73","author":"AI Bernstein","year":"2014","unstructured":"Bernstein AI, Stout KA, Miller GW (2014) The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int 73:89\u201397. https:\/\/doi.org\/10.1016\/j.neuint.2013.12.003","journal-title":"Neurochem Int"},{"issue":"20","key":"6164_CR51","doi-asserted-by":"publisher","first-page":"11849","DOI":"10.1021\/acsomega.0c01818","volume":"5","author":"B Salehi","year":"2020","unstructured":"Salehi B, Machin L, Monzote L, Sharifi-Rad J, Ezzat SM, Salem MA, Merghany RM, El Mahdy NM et al (2020) Therapeutic potential of quercetin: new insights and perspectives for human health. ACS Omega 5(20):11849\u201311872. https:\/\/doi.org\/10.1021\/acsomega.0c01818","journal-title":"ACS Omega"},{"issue":"5","key":"6164_CR52","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.3390\/molecules29051000","volume":"29","author":"EJ Carrillo-Martinez","year":"2024","unstructured":"Carrillo-Martinez EJ, Flores-Hern\u00e1ndez FY, Salazar-Montes AM, Nario-Chaidez HF, Hern\u00e1ndez-Ortega LD (2024) Quercetin, a flavonoid with great pharmacological capacity. Molecules 29(5):1000. https:\/\/doi.org\/10.3390\/molecules29051000","journal-title":"Molecules"},{"key":"6164_CR53","doi-asserted-by":"publisher","first-page":"2986796","DOI":"10.1155\/2016\/2986796","volume":"1","author":"LG Costa","year":"2016","unstructured":"Costa LG, Garrick JM, Roqu\u00e8 PJ (2016) Pellacani C (2016) Mechanisms of neuroprotection by quercetin: counteracting oxidative stress and more. Oxid Med Cell Longev 1:2986796. https:\/\/doi.org\/10.1155\/2016\/2986796","journal-title":"Oxid Med Cell Longev"},{"key":"6164_CR54","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.3390\/molecules24061123","volume":"24","author":"D Xu","year":"2019","unstructured":"Xu D, Hu MJ, Wang YQ, Cui YL (2019) Antioxidant activities of quercetin and its complexes for medicinal application. Molecules 24:1123. https:\/\/doi.org\/10.3390\/molecules24061123","journal-title":"Molecules"},{"issue":"4","key":"6164_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/life12040591","volume":"12","author":"D Wr\u00f3bel-Biedrawa","year":"2022","unstructured":"Wr\u00f3bel-Biedrawa D, Grabowska K, Galanty A, Sobolewska D, Podolak I (2022) A flavonoid on the brain: quercetin as a potential therapeutic agent in central nervous system disorders. Life (Basel) 12(4):591. https:\/\/doi.org\/10.3390\/life12040591","journal-title":"Life (Basel)"},{"issue":"3","key":"6164_CR56","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/molecules24030418","volume":"24","author":"P Dhiman","year":"2019","unstructured":"Dhiman P, Malik N, Sobarzo-S\u00e1nchez E, Uriarte E, Khatkar A (2019) Quercetin and related chromenone derivatives as monoamine oxidase inhibitors: targeting neurological and mental disorders. Molecules 24(3):418. https:\/\/doi.org\/10.3390\/molecules24030418","journal-title":"Molecules"},{"issue":"2","key":"6164_CR57","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2174\/1573406410666140925151845","volume":"11","author":"B Yulug","year":"2015","unstructured":"Yulug B, Hanoglu L, Kilic E (2015) The neuroprotective role of vesicular monoamine transporter 2 in neurodegenerative diseases. Med Chem (Los Angeles) 11(2):104\u20138. https:\/\/doi.org\/10.2174\/1573406410666140925151845","journal-title":"Med Chem (Los Angeles)"},{"issue":"1","key":"6164_CR58","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/toxsci\/kfw106","volume":"153","author":"KM Lohr","year":"2016","unstructured":"Lohr KM, Chen M, Hoffman CA, McDaniel MJ, Stout KA, Dunn AR et al (2016) Vesicular monoamine transporter 2 (VMAT2) level regulates MPTP vulnerability and clearance of excess dopamine in mouse striatal terminals. Toxicol Sci 153(1):79\u201388. https:\/\/doi.org\/10.1093\/toxsci\/kfw106","journal-title":"Toxicol Sci"},{"key":"6164_CR59","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.pneurobio.2016.04.001","volume":"151","author":"G \u0160imi\u0107","year":"2017","unstructured":"\u0160imi\u0107 G, Leko MB, Wray S, Harrington CR, Delalle I, Jovanov-Milo\u0161evi\u0107 N et al (2017) Monoaminergic neuropathology in Alzheimer\u2019s disease. Prog Neurobiol 151:101\u201338. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.04.001","journal-title":"Prog Neurobiol"},{"key":"6164_CR60","doi-asserted-by":"publisher","unstructured":"Ka\u015f\u0131kc\u0131 MB, Ba\u011fdatl\u0131o\u011flu N (2016) Bioavailability of quercetin. Curr Res Nutr Food Sci 4(Special Issue):146. https:\/\/doi.org\/10.12944\/CRNFSJ.4.Special-Issue-October.20","DOI":"10.12944\/CRNFSJ.4.Special-Issue-October.20"},{"issue":"7","key":"6164_CR61","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/ph16071020","volume":"16","author":"F Aghababaei","year":"2023","unstructured":"Aghababaei F, Hadidi M (2023) Recent advances in potential health benefits of quercetin. Pharmaceuticals 16(7):1020. https:\/\/doi.org\/10.3390\/ph16071020","journal-title":"Pharmaceuticals"},{"issue":"12","key":"6164_CR62","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/mnfr.201100378","volume":"55","author":"C Menendez","year":"2011","unstructured":"Menendez C, Due\u00f1as M, Galindo P, Gonz\u00e1lez-Manzano S, Jimenez R, Moreno L et al (2011) Vascular deconjugation of quercetin glucuronide: the flavonoid paradox revealed? Mol Nutr Food Res 55(12):1780\u201390. https:\/\/doi.org\/10.1002\/mnfr.201100378","journal-title":"Mol Nutr Food Res"},{"issue":"3","key":"6164_CR63","first-page":"5","volume":"13","author":"CY Yang","year":"2005","unstructured":"Yang CY, Hsiu SL, Wen KC, Lin SP, Tsai SY, Hou YC et al (2005) Bioavailability and metabolic pharmacokinetics of rutin and quercetin in rats. J Food Drug Anal 13(3):5","journal-title":"J Food Drug Anal"},{"issue":"4","key":"6164_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1517\/14740330903026944","volume":"8","author":"B Ossola","year":"2009","unstructured":"Ossola B, K\u00e4\u00e4ri\u00e4inen TM, M\u00e4nnist\u00f6 PT (2009) The multiple faces of quercetin in neuroprotection. Expert Opin Drug Saf 8(4):397\u2013409. https:\/\/doi.org\/10.1517\/14740330903026944","journal-title":"Expert Opin Drug Saf"},{"issue":"2","key":"6164_CR65","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3892\/or.2017.5766","volume":"38","author":"M Hashemzaei","year":"2017","unstructured":"Hashemzaei M, Delarami Far A, Yari A, Heravi RE, Tabrizian K, Taghdisi SM et al (2017) Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo. Oncol Rep 38(2):819\u201328. https:\/\/doi.org\/10.3892\/or.2017.5766","journal-title":"Oncol Rep"},{"issue":"8","key":"6164_CR66","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1086\/512858","volume":"195","author":"JE Gern","year":"2007","unstructured":"Gern JE, Mosser AG, Swenson CA, Rennie PJ, England RJ, Shaffer J et al (2007) Inhibition of rhinovirus replication in vitro and in vivo by acid-buffered saline. J Infect Dis 195(8):1137\u201343. https:\/\/doi.org\/10.1086\/512858","journal-title":"J Infect Dis"},{"issue":"9","key":"6164_CR67","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/jn\/138.9.1615","volume":"138","author":"S Egert","year":"2008","unstructured":"Egert S, Wolffram S, Bosy-Westphal A, Boesch-Saadatmandi C, Wagner AE, Frank J et al (2008) Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J Nutr 138(9):1615\u201321. https:\/\/doi.org\/10.1093\/jn\/138.9.1615","journal-title":"J Nutr"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06164-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-026-06164-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-026-06164-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T01:55:57Z","timestamp":1787882157000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-026-06164-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["6164"],"URL":"https:\/\/doi.org\/10.1007\/s12035-026-06164-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"18 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"862"}}